VCYT
Veracyte IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$3.59B
P/E Ratio
41.69
EPS
$1.08
Beta
1.89
52W High
$50.71
52W Low
$22.61
50-Day MA
$34.97
200-Day MA
$36.73
Dividend Yield
—
Profit Margin
16.30%
Forward P/E
26.32
PEG Ratio
0.00
About Veracyte Inc
Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $541.74M |
| Gross Profit (TTM) | $394.97M |
| EBITDA | $104.21M |
| Operating Margin | 16.30% |
| Return on Equity | 6.93% |
| Return on Assets | 3.76% |
| Revenue/Share (TTM) | $6.86 |
| Book Value | $16.50 |
| Price-to-Book | 2.68 |
| Price-to-Sales (TTM) | 6.63 |
| EV/Revenue | 5.92 |
| EV/EBITDA | 28.58 |
| Quarterly Earnings Growth (YoY) | 288.90% |
| Quarterly Revenue Growth (YoY) | 21.50% |
| Shares Outstanding | $79.79M |
| Float | $79.36M |
| % Insiders | 0.52% |
| % Institutions | 113.25% |
Historical Volatility
HV 10-Day
60.21%
HV 20-Day
92.62%
HV 30-Day
79.01%
HV 60-Day
67.55%
HV Rank
86.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($47.40 target)
1
Strong Buy9
Buy1
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026